1. Billman, J. H. and Tonnis, J. A., Substituted aralkyl aldehydes: preparation and antitumor evaluation.J. Pharm. Sci., 60, 1188–1192 (1971).
2. Dornish, J. M., Petterson, E. O. and Oftebro, R., Modifying effect of cinnamaldehyde and cinnamaldehyde derivatives on cell inactivation and cellular uptake of cis-diamminedichloroplatinum (II) in human NHIK 3025 cells.Cancer Res., 49, 3917–3921 (1989).
3. Goldin, A., Serpick, A. A., Mantel, N., Experimental screening procedures and clinical predictability value.Cancer Chemoth. Rep., 50, 190–231 (1966).
4. Kwon, B. M., Cho, Y. K., Lee, S. H., Nam, J. Y., Bok, S. H., Chun, S. K., Kim, J. A. and Lee, I. R., 2′-Hydroxycinnamaldehyde from stem bark ofcinnamomum cassia.Planta Med., 62, 193–184 (1996).
5. Kwon, B. M., Lee, S. H., Cho, Y. K., Bok, S. H., So, S. H., Youn, M. R. and Chang, S. I., Synthesis and biological activity of cinnamaldehydes as angiogenesis inhibitors.Bioorg. Med. Chem. Letters, 7, 2473–2476 (1997).